A detailed history of Skba Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Skba Capital Management LLC holds 20,560 shares of AMGN stock, worth $5.76 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares
20,560
Previous 21,110 2.61%
Holding current value
$5.76 Million
Previous $6.6 Million 0.44%
% of portfolio
1.03%
Previous 1.1%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$309.38 - $337.38 $170,159 - $185,559
-550 Reduced 2.61%
20,560 $6.62 Million
Q2 2024

Aug 12, 2024

SELL
$262.75 - $319.31 $77,774 - $94,515
-296 Reduced 1.38%
21,110 $6.6 Million
Q1 2024

May 13, 2024

SELL
$268.87 - $324.56 $68,561 - $82,762
-255 Reduced 1.18%
21,406 $6.09 Million
Q4 2023

Feb 12, 2024

SELL
$255.7 - $288.46 $5.01 Million - $5.65 Million
-19,600 Reduced 47.5%
21,661 $6.24 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $2.35 Million - $2.77 Million
10,950 Added 36.13%
41,261 $9.16 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $11,289 - $13,760
50 Added 0.17%
30,311 $7.33 Million
Q4 2022

Feb 10, 2023

SELL
$229.03 - $291.01 $2.44 Million - $3.1 Million
-10,650 Reduced 26.03%
30,261 $7.95 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $16,834 - $18,986
75 Added 0.18%
40,911 $9.22 Million
Q2 2022

Aug 12, 2022

SELL
$230.71 - $256.74 $992,053 - $1.1 Million
-4,300 Reduced 9.53%
40,836 $9.94 Million
Q1 2022

May 12, 2022

SELL
$219.27 - $242.57 $40,345 - $44,632
-184 Reduced 0.41%
45,136 $10.9 Million
Q4 2021

Feb 10, 2022

SELL
$198.88 - $227.6 $2.89 Million - $3.31 Million
-14,550 Reduced 24.3%
45,320 $10.2 Million
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $2.57 Million - $2.85 Million
-11,000 Reduced 15.52%
59,870 $14.6 Million
Q1 2021

May 13, 2021

SELL
$221.91 - $258.6 $998,595 - $1.16 Million
-4,500 Reduced 5.97%
70,870 $17.6 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $3.92 Million - $4.66 Million
18,100 Added 31.6%
75,370 $17.3 Million
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $793,117 - $882,011
-3,380 Reduced 5.57%
57,270 $14.6 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $98,905 - $121,370
-500 Reduced 0.82%
60,650 $14.3 Million
Q4 2019

Feb 12, 2020

SELL
$189.21 - $243.2 $662,235 - $851,200
-3,500 Reduced 5.41%
61,150 $14.7 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $1.78 Million - $2.13 Million
10,200 Added 18.73%
64,650 $12.5 Million
Q2 2019

Aug 12, 2019

SELL
$166.7 - $195.41 $1.92 Million - $2.25 Million
-11,500 Reduced 17.44%
54,450 $10 Million
Q1 2019

May 13, 2019

SELL
$180.87 - $203.88 $1.14 Million - $1.28 Million
-6,300 Reduced 8.72%
65,950 $12.5 Million
Q4 2018

Feb 07, 2019

SELL
$178.4 - $208.25 $936,600 - $1.09 Million
-5,250 Reduced 6.77%
72,250 $14.1 Million
Q3 2018

Nov 09, 2018

BUY
$185.29 - $208.89 $3.87 Million - $4.37 Million
20,900 Added 36.93%
77,500 $16.1 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $91,327 - $102,580
-550 Reduced 0.96%
56,600 $10.4 Million
Q1 2018

May 08, 2018

BUY
$169.43 - $198.0 $33,886 - $39,600
200 Added 0.35%
57,150 $9.74 Million
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $632,962 - $707,212
3,750 Added 7.05%
56,950 $9.9 Million
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $8.9 Million - $10.2 Million
53,200
53,200 $9.92 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $150B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Skba Capital Management LLC Portfolio

Follow Skba Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Skba Capital Management LLC with notifications on news.